All articles

• cautionary taleThe Barbie drug: how an unapproved peptide built a global gray market

  Melanotan II was never approved anywhere, for anything. It sold anyway — through forums, gyms, and 'research chemical' sites. This is what that market looks like and what it costs.

• cultureHow a suntan became desirable

  For most of history, pale skin meant status and a tan meant labor. Then, in one decade, it flipped. The century that made a tan aspirational — Chanel, the Riviera, the sunbed — and set up everything that came after.

• scienceHow a tan actually protects skin — and why that was the whole idea

  A tan is the body's own sunscreen: eumelanin absorbing ultraviolet before it reaches DNA. Understanding how melanin protects — and how little — is the key to what Melanotan was reaching for.

• historyHow the science escaped the lab: the patents that made a gray market inevitable

  Melanotan II's structure was published in journals and patents, then orphaned by its own developers. Once the recipe was public and the demand was real, the gray market was only a matter of time.

• historyMelanotan I and Melanotan II: one number, two completely different fates

  Two peptides from the same Arizona lab, almost the same molecule. One became an approved medicine. The other became the gray market's favorite. The difference is a lesson in selectivity.

• next agonistThe middle-ground agonist already exists. You just can't have it.

  Afamelanotide (Scenesse) is an approved, rigorously tested melanocortin drug that protects skin from light. Why it's locked in a rare-disease label — and what a GLP-1-style breakout would take.

• scienceOne hormone, five receptors: why Melanotan II did so much more than tan

  MT-II's strange effect profile — tanning, appetite, libido — isn't mysterious. It's what happens when a non-selective agonist hits the whole melanocortin receptor family at once.

• cultureTanorexia: the opioid your skin makes in the sun

  Why is a tan so hard to give up? UV light makes your skin manufacture a real opioid. The addiction science — mice, naloxone, and eight frequent tanners — and what it explains about a peptide.

• historyOne injection, eight hours, and a second drug hiding inside Melanotan II

  The strangest chapter in the Melanotan story: a University of Arizona self-experiment that produced an eight-hour erection — and pointed the way to an FDA-approved libido drug.

• next agonistThe beachhead: the narrow uses that could open the door for everyone

  GLP-1 reached the masses through diabetes first. A photoprotective melanocortin drug has its own candidate beachheads — and one of them, vitiligo, is in Phase III right now.

• cultureThe influencer era: how the Barbie drug got re-sold

  Melanotan II never went away — it went viral. Nasal sprays, flavored drops, and the 'vacation peptide' on TikTok. How social media re-packaged an unregulated injectable, and the regulatory gap that lets it sell in the open.

• cautionary taleThe mole problem: what dermatologists actually fear about Melanotan II

  Melanotan II darkens and multiplies moles — and the deeper danger is diagnostic. The case reports, the unresolved melanoma question, and why a changing mole is the exact signal you don't want to lose.

• next agonistThe prevention-trial problem: why 'stops skin cancer' is so hard to prove

  A drug that prevents skin cancer in healthy people would need one of the longest, largest, most expensive trials in medicine. Why the evidence bar — not the chemistry — is the real wall.

• cautionary taleThe side-effect ledger: what Melanotan II is actually documented to do

  Separating what Melanotan II reliably does from forum lore and worst-case rumor: the acute effects, the pigment effects, and the rare serious events that actually reach the medical literature.

• scienceThe tan without the sun: what a peptide short-circuits that UV does the hard way

  A suntan is a wound response — pigment the skin makes only after ultraviolet has already damaged its DNA. Melanotan's elegant idea was to get the pigment without the damage that normally triggers it.

• next agonistThe three doors: the U.S. regulatory map for a melanocortin sun drug

  Melanotan II is illegal in America — but the technology it previewed is not. A primer on the U.S. regulatory landscape (FDA approval, compounding, and the gray market) for the melanocortin agonists that give skin photoprotection without the sun.

• next agonistWhat a safe tanning drug would actually have to be

  Not a vial from a forum — a real one. The four things a general-public photoprotective drug would need to clear, and how far today's science already is toward each. Analysis, labeled as such.

• cautionary taleYou can't know what's in the vial

  Gray-market Melanotan II is an unregulated injectable, made by unknown labs and reconstituted at the kitchen table. Purity, sterility, and dose are all assumptions — and assumptions have sent people to the ER.

• historyThe sunscreen you'd never have to reapply: where Melanotan came from

  Melanotan II wasn't invented for tanning salons. It came out of 1980s melanoma-prevention research at the University of Arizona — and the original goal was saving lives.

• cultureWhy a cosmetic went underground

  Melanotan II may be the most self-injected drug no regulator ever approved. The reason isn't only lax enforcement — it's that it served a want, not a need, and wants don't wait for clinical trials.

• scienceWhy redheads burn: the MC1R gene and the pigment switch

  Red hair, freckles, and burning instead of tanning all trace to one receptor: MC1R. It's the same keyhole every Melanotan was cut to fit — and a melanoma risk gene in its own right.